These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
25. Effect of methenamine hippurate shortage on antibiotic prescribing for urinary tract infections in Norway-an interrupted time series analysis. Heltveit-Olsen SR; Gopinathan U; Blix HS; Elstrøm P; Høye S J Antimicrob Chemother; 2024 May; 79(5):1109-1117. PubMed ID: 38635298 [TBL] [Abstract][Full Text] [Related]
26. [Comparison of the effectiveness of methenamine hippurate and nitrofurantoin in the prevention of recurrence of urinary tract infections]. Krzymanski M; Grabski T; Suwała W Pol Arch Med Wewn; 1982; 67(1-2):23-8. PubMed ID: 7111046 [No Abstract] [Full Text] [Related]
27. Effect of urine pH and ascorbic acid on the rate of conversion of methenamine to formaldehyde. Strom JG; Jun HW Biopharm Drug Dispos; 1993 Jan; 14(1):61-9. PubMed ID: 8427945 [TBL] [Abstract][Full Text] [Related]
29. The effect of short-term high-dose treatment with methenamine hippurate of urinary infection in geriatric patients with indwelling catheters. II. Evaluation by means of a quantified urine sediment. Norberg A; Norberg B; Parkhede U; Gippert H; Ekman R Ups J Med Sci; 1979; 84(1):75-82. PubMed ID: 442280 [TBL] [Abstract][Full Text] [Related]
30. Long-term prophylaxis with methenamine hippurate in girls with recurrent urinary tract infections. Petersen S Acta Paediatr Scand; 1978 Sep; 67(5):597-9. PubMed ID: 358737 [TBL] [Abstract][Full Text] [Related]
31. Secondary prevention of recurrent urinary tract infections. Comparison of the effect of placebo, methenamine hippurate, nitrofurantoin and trimethoprim alone. Kasanen A; Junnila SY; Kaarsalo E; Hajba A; Sundquist H Scand J Infect Dis; 1982; 14(4):293-6. PubMed ID: 6761854 [TBL] [Abstract][Full Text] [Related]
32. Methenamine hippurate ('Hiprex') in the treatment of chronic urinary tract infections: a trial in a geriatric hospital. Parvio S J Int Med Res; 1976; 4(2):111-4. PubMed ID: 1026539 [TBL] [Abstract][Full Text] [Related]
33. Effect of chronic administration of ammonium sulfate on phosphatic stone recurrence. Pizzarelli F; Peacock M Nephron; 1987; 46(3):247-52. PubMed ID: 3627318 [TBL] [Abstract][Full Text] [Related]
35. An approach to the management of resistant urinary infections. Kass EH Kidney Int; 1979 Aug; 16(2):204-12. PubMed ID: 513507 [No Abstract] [Full Text] [Related]
36. The effect of short-term high-dose treatment with methenamine hippurate of urinary infection in geriatric patients with indwelling catheters. I. The preparation and morphology of a quantified urine sediment. Norberg B; Norberg A; Parkhede U; Gippert H; Akerman M Ups J Med Sci; 1979; 84(1):67-74. PubMed ID: 87049 [TBL] [Abstract][Full Text] [Related]
37. Comparison of long-term, low-dosage nitrofurantoin, methenamine hippurate, trimethoprim and trimethoprim-sulphamethoxazole on the control of recurrent urinary tract infection. Kasanen A; Kaarsalo E; Hiltunen R; Soini V Ann Clin Res; 1974 Oct; 6(5):285-9. PubMed ID: 4475571 [No Abstract] [Full Text] [Related]
38. [Preventive measures in stones due to infection, uric acid and cystine]. Hess B; Ackermann D Ther Umsch; 1992 Jan; 49(1):44-8. PubMed ID: 1736401 [TBL] [Abstract][Full Text] [Related]
39. [Association of hexamethylenetetramine vitamin C in urinary infections]. OBERHOLTZER A Urologia; 1948 Oct; 15(5):376. PubMed ID: 18101342 [No Abstract] [Full Text] [Related]
40. [Hiprex in favour again?]. Norberg B Lakartidningen; 2011 Jun 1-14; 108(22-23):1255. PubMed ID: 21786504 [No Abstract] [Full Text] [Related] [Previous] [Next] [New Search]